Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C200 - Spinocerebellar and Spastic Ataxias: Diagnosis and Management

Thursday 04/27/23
01:00 PM - 03:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Oksana Suchowersky, MD, FAAN
Movement Disorders
Participants will become familiar with the differential diagnoses, investigation, and management of patients with spinocerebellar and spastic ataxias. Particular attention will be given to benefits and limitations of genetic testing, update on pathophysiology, and potential for new and genetic therapies.

This program is supported in part by an educational grant from Reata Pharmaceuticals

The Academy was solely responsible, with no influence from the industry supporter, for selection of content, format, presenters, and moderators of this CME program, and the speakers have not been contacted or influenced in any way by the industry supporter with regard to this CME program.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:40 PM EST Speaker SCAs and Spastic Ataxias: Clinical Features and Diagnosis
Oksana Suchowersky, MD, FAAN
01:40 PM - 02:20 PM EST Speaker Pathogenesis and New Therapeutic Options
Massimo Pandolfo, MD, FAAN
02:20 PM - 03:00 PM EST Discussion Case Presentations and Discussion
Oksana Suchowersky, MD, FAAN, Massimo Pandolfo, MD, FAAN
Faculty Disclosures
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minoryx. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.